Pneumococcal pneumonia in the UK—how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV)-Reference-Cited by-同舟云学术

Pneumococcal pneumonia in the UK—how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV)

Published:2005-02 Issue:14 Volume:23 Page:1739-1745
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

McIntosh E.D.G.,Conway P.,Willingham J.,Hollingsworth R.,Lloyd A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference37 articles.

1. Donaldson L, Mullally S, Smith J. Adult immunisation. From the Chief Medical Officer, the Chief Nursing Officer and the Chief Pharmaceutical Officer. 8 August 2003 (http://www.doh.gov.uk/cmo/letters/cmo0306.htm).

2. The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine;McIntosh;Vaccine,2003

3. Herd immunity: basic concept and relevance to public health immunization practices;Fox;Am J Epidemiol,1971

4. Herd immunity: history, theory, practice;Fine;Epidemiol Rev,1993

5. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis;Ramsay;Br Med J,2003

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness analysis of pediatric immunization program with 15-valent pneumococcal conjugate vaccine in Japan;Journal of Medical Economics;2023-08-18

2. Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population;Vaccines;2023-01-06

3. Economic Analyses of Vaccine Policies;Plotkin's Vaccines;2023

4. Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study;BMC Infectious Diseases;2020-06-17

5. Pneumococcal Disease: A Systematic Review of Health Utilities, Resource Use, Costs, and Economic Evaluations of Interventions;Value in Health;2019-11